Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

The bioavailability and nonlinear pharmacokinetics of MK-679 in humans.

Cheng H, Schwartz JI, Lin C, Amin RD, Seibold JR, Lasseter KC, Ebel DL, Tocco DJ, Rogers JD.

Biopharm Drug Dispos. 1994 Jul;15(5):409-18.

PMID:
7981429
2.

Physiological disposition of aerosolized MK-679 in rats.

Tocco DJ, deluna FA, Vadas E, Lin JH.

Drug Metab Dispos. 1992 May-Jun;20(3):428-31.

PMID:
1355719
3.

Species-dependent enantioselective plasma protein binding of MK-571, a potent leukotriene D4 antagonist.

Lin JH, deLuna FA, Ulm EH, Tocco DJ.

Drug Metab Dispos. 1990 Jul-Aug;18(4):484-7.

PMID:
1976072
4.

Interspecies differences in stereoselective protein binding and clearance of MK-571.

Tocco DJ, deLuna FA, Duncan AE, Hsieh JH, Lin JH.

Drug Metab Dispos. 1990 Jul-Aug;18(4):388-92.

PMID:
1976057
5.

Effect of experimental diabetes on elimination kinetics of diflunisal in rats.

Lin JH, DeLuna FA, Tocco DJ, Ulm EH.

Drug Metab Dispos. 1989 Mar-Apr;17(2):147-52.

PMID:
2565203
6.
7.

Disposition and metabolism of sodium 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate in rats and dogs.

Tocco DJ, deLuna FA, Duncan AE, Ramjit HG, Pitzenberger SM, Hsieh JY.

Drug Metab Dispos. 1988 Sep-Oct;16(5):690-6.

PMID:
2906591
9.

Assay methodology for quantification of the ester and ether glucuronide conjugates of diflunisal in human urine.

Musson DG, Lin JH, Lyon KA, Tocco DJ, Yeh KC.

J Chromatogr. 1985 Feb 8;337(2):363-78.

PMID:
3838756
10.

Diflunisal-induced maternal anemia as a cause of teratogenicity in rabbits.

Clark RL, Robertson RT, Minsker DH, Cohen SM, Tocco DJ, Allen HL, James ML, Bokelman DL.

Teratology. 1984 Dec;30(3):319-32.

PMID:
6515560
11.

The physiological disposition and metabolism of enalapril maleate in laboratory animals.

Tocco DJ, deLuna FA, Duncan AE, Vassil TC, Ulm EH.

Drug Metab Dispos. 1982 Jan-Feb;10(1):15-9.

PMID:
6124377
12.

Urinary metabolites of timolol from humans and laboratory animals. Syntheses and beta-adrenergic blocking activities.

Wasson BK, Scheigetz J, Rooney CS, Hall RA, Share NN, VandenHeuvel WJ, Arison BH, Hensens OD, Ellsworth RL, Tocco DJ.

J Med Chem. 1980 Nov;23(11):1178-84.

PMID:
6109024
13.

Timolol metabolism in man and laboratory anamals.

Tocco DJ, Duncan AE, deLuna FA, Smith JL, Walker RW, Vandenheuvel WJ.

Drug Metab Dispos. 1980 Jul-Aug;8(4):236-40.

PMID:
6105057
14.

Uptake of the beta-adrenergic blocking agents propranolol and timolol by rodent brain: relationship to central pharmacological actions.

Tocco DJ, Clineschmidt BV, Duncan AE, deLuna FA, Baer JE.

J Cardiovasc Pharmacol. 1980;2(2):133-43. No abstract available.

PMID:
6171681
15.
16.

Physiological disposition and metabolism of 2-aminomethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride.

Tocco DJ, deLuna FA, Duncan AE, Walker RW, Arison BH, Vandenheuvel WJ.

Drug Metab Dispos. 1979 Sep-Oct;7(5):330-4.

PMID:
40776
17.

An electron-capture gas chromatographic procedure for the estimation of oxalic acid in urine.

Tocco DJ, Duncan AE, Noll RM, Duggan DE.

Anal Biochem. 1979 Apr 15;94(2):470-6. No abstract available.

PMID:
464317
18.

Stereospecific binding of timolol, a beta-adrenergic blocking agent.

Tocco DJ, Hooke KF, Deluna FA, Duncan AE.

Drug Metab Dispos. 1976 Jul-Aug;4(4):323-9.

PMID:
8286
19.

Electron-capture GLC determination of timolol in human plasma and urine.

Tocco DJ, deLuna FA, Duncan AE.

J Pharm Sci. 1975 Nov;64(11):1879-81.

PMID:
1195122
20.

Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.

Tocco DJ, Breault GO, Zacchei AG, Steelman SL, Perrier CV.

Drug Metab Dispos. 1975 Nov-Dec;3(6):453-66.

PMID:
1220
21.

Physiological disposition and metabolism of timolol in man and laboratory animals.

Tocco DJ, Duncan AE, Delauna FA, Hucker HB, Gruber VF, Vandenheuvel WJ.

Drug Metab Dispos. 1975 Sep-Oct;3(5):361-70.

PMID:
241617
22.

Absorption, metabolism, and excretion of thiabendazole in man and laboratory animals.

Tocco DJ, Rosenblum C, Martin CM, Robinson HJ.

Toxicol Appl Pharmacol. 1966 Jul;9(1):31-9. No abstract available.

PMID:
5967564
23.

Gastrointestinal absorption and secretion of thiabendazole in ruminants.

McManus EC, Washko FV, Tocco DJ.

Am J Vet Res. 1966 Jul;27(119):849-55. No abstract available.

PMID:
5967331
24.

Absorption, metabolism and elimination of thiabendazole in farm animals and a method for its estimation in biological materials.

Tocco DJ, Egerton JR, Bowers W, Christensen VW, Rosenblum C.

J Pharmacol Exp Ther. 1965 Aug;149(2):263-71. No abstract available.

PMID:
5831047
25.

THE METABOLIC FATE OF THIABENDAZOLE IN SHEEP.

TOCCO DJ, BUHS RP, BROWN HD, MATZUK AR, MERTEL HE, HARMAN RE, TRENNER NR.

J Med Chem. 1964 Jul;7:399-405. No abstract available.

PMID:
14221114
26.

INTERACTION OF PURINES WITH THE PYRIMIDINE TRANSPORT PROCESS OF THE SMALL INTESTINE.

SCHANKER LS, JEFFREY JJ, TOCCO DJ.

Biochem Pharmacol. 1963 Sep;12:1047-53. No abstract available.

PMID:
14068500
27.

Some characteristics of the pyrimidine transport process of the small intestine.

SCHANKER LS, TOCCO DJ.

Biochim Biophys Acta. 1962 Jan 29;56:469-73. No abstract available.

PMID:
14498024
28.

Active transport of some pyrimidines across the rat intestinal epithelium.

SCHANKER LS, TOCCO DJ.

J Pharmacol Exp Ther. 1960 Feb;128:115-21. No abstract available.

PMID:
14442418
29.

On the mechanism of intestinal absorption of drugs.

HOGBEN CA, TOCCO DJ, BRODIE BB, SCHANKER LS.

J Pharmacol Exp Ther. 1959 Apr;125(4):275-82. No abstract available.

PMID:
13642268
30.

Absorption of drugs from the rat small intestine.

SCHANKER LS, TOCCO DJ, BRODIE BB, HOGBEN CA.

J Pharmacol Exp Ther. 1958 May;123(1):81-8. No abstract available.

PMID:
13539795
31.

Absorption of drugs from the stomach. II. The human.

HOGBEN CA, SCHANKER LS, TOCCO DJ, BRODIE BB.

J Pharmacol Exp Ther. 1957 Aug;120(4):540-5. No abstract available.

PMID:
13476378

Supplemental Content

Loading ...
Support Center